Learn

In March 2024, Sanofi Australia facilitated a national speaker tour with Professor Liam Heaney from Queens University Belfast, Northern Ireland. Attendees were treated to a contemporary and thought-provoking presentation, divided into two parts. In the first, Professor Heaney introduced the concept of a ‘bomb’ (blood eosinophils) meets ‘magnet’ [fractional exhaled nitric oxide (FeNO)] framework to describe different components of type-2 inflammation in severe asthma and the potential for biomarker profiling of patients with monitored inhaled corticosteroid (ICS) treatment. In the second, Professor Heaney discussed the role of the UK Severe Asthma Registry (UKSAR), providing highlights from several recently published studies. This review summarises key messages from Professor Heaney’s presentation and incorporates practical considerations for achieving optimal outcomes for patients with severe asthma.

Details

A summary of a recent presentation titled: Breath of innovation; Navigating respiratory frontiers with Professor Liam Heaney. The presentation explores the components of type-2 inflammation in severe asthma and the potential for biomarker profiling of patients with monitored inhaled corticosteroid treatment.

This activity is accepted by CPD Home as a Domain 1: Educational Activity - Professional Reading in alignment with the CPD Home Program Guide. 

Disclaimer: Please note, once you click 'Enrol now' you will be leaving the AMA’s CPD Home website and entering a third-party website.